Insurance for unexpected expenses in case of complications during treatment and 48 months after treatment Coverage up to 200,000 USD


Dr.Jaume Mora Graupera (Pediatric hematologist/oncologist, Pediatric oncologist)– Best Costs, Reviews – Book Your Consultation
Dr. Jaume Mora Graupera is a world-renowned pediatric hematologist-oncologist and researcher, serving as the Scientific Director of the Oncology and Hematology Department at SJD Barcelona Children’s Hospital in Spain. He is known internationally for his pioneering work in childhood solid tumors and precision cancer therapies.
- Full name: Dr. Jaume Mora Graupera, MD, PhD
- Main specialty: Pediatric Oncology and Hematology
- Years of experience: Over two decades in clinical practice and oncology research
Educational Background
- Medical degree from the University of Barcelona, Spain
- Residency in Pediatrics at SJD Barcelona Children’s Hospital
- Fellowship in Pediatric Oncology at Memorial Sloan Kettering Cancer Center, New York, USA
- PhD in Molecular Biology from Universitat Autònoma de Barcelona
- Completed multiple international training programs in oncogenetics and experimental therapeutics
Professional Experience
- Currently serves as Scientific Director of the Pediatric Oncology and Hematology Department at SJD Barcelona Children’s Hospital
- Director of the Developmental Tumor Biology Laboratory at the Sant Joan de Déu Research Institute
- Leader in the development of the Pediatric Cancer Center Barcelona, a reference model for integrated childhood cancer care
- Extensive experience managing rare and complex pediatric cancers
Academic Contributions
- Professor of Pediatric Oncology at the University of Barcelona
- Developed and led advanced clinical research programs on pediatric tumors
- Speaker at international oncology conferences in Europe, the US, and Latin America
- Mentor to medical students, fellows, and early-career oncologists worldwide
Areas of Expertise
Dr. Mora specializes in the biological understanding and clinical management of pediatric solid tumors. His approach combines translational research and precision medicine for improved survival outcomes in children.
- Neuroblastoma: Focuses on high-risk neuroblastoma and experimental treatment strategies
- Retinoblastoma: Expert in eye-preserving therapies and genetic management of retinoblastoma
- Ewing Sarcoma and Osteosarcoma: Treats bone tumors using multi-modal therapies and clinical trials
- Medulloblastoma: Provides state-of-the-art treatment for pediatric brain tumors
- Relapsed and refractory cancers: Offers advanced molecular testing and targeted therapies
Publications and Research
Dr. Jaume Mora is a prolific researcher with numerous publications in high-impact medical journals. His work focuses on the molecular mechanisms of childhood cancers and the development of new treatment pathways.
Some of his published contributions include:
- Studies on the role of ALK mutations in neuroblastoma progression and therapy
- Collaborative research on molecular signatures in Ewing sarcoma
- Peer-reviewed papers on the application of personalized medicine in pediatric oncology
He actively contributes to PubMed-indexed journals and leads cross-disciplinary research teams within international pediatric oncology networks.
Patient Care Philosophy
- Dr. Mora is committed to delivering holistic, science-driven care with empathy and precision
- Advocates for personalized therapy based on tumor biology, genetics, and patient needs
- Collaborates closely with families and multidisciplinary teams for every treatment decision
- Supports international families through online consultations and long-term care planning
- Committed to patient dignity, emotional well-being, and transparent communication
Professional Affiliations
- Member of the European Society for Paediatric Oncology (SIOP Europe)
- Member of the American Society of Clinical Oncology (ASCO)
- Founder of multiple pediatric cancer research initiatives in Spain
- Licensed specialist in Pediatric Hematology and Oncology in Spain
FAQs
- Is Dr. Jaume Mora Graupera board-certified?
- Yes, he is a certified pediatric hematologist-oncologist in Spain with international training.
- What types of surgeries or treatments does he perform?
- He leads advanced protocols for treating solid tumors, including chemotherapy, immunotherapy, and molecular-targeted therapy. While not a surgeon, he collaborates with leading pediatric surgical teams.
- Does he treat international patients?
- Yes, Dr. Mora treats patients from around the world and works closely with the international office at SJD Barcelona Children’s Hospital.
- How long is the typical hospital stay for pediatric oncology treatment?
- The duration depends on the diagnosis and treatment stage. Some protocols require multiple inpatient visits over several months.
- What languages does he speak?
- Dr. Mora speaks Spanish, Catalan, and English fluently. Interpreter services are also available at the hospital.
- Can international families request a remote consultation?
- Yes, remote consultations and second opinions are available to support diagnosis and treatment planning before travel.
- Is Dr. Mora involved in clinical trials?
- Yes, he leads numerous clinical trials focused on pediatric cancers and experimental therapies at both national and European levels.
Certification & Accreditation



Patient reviews
Patient reviews
